ArticleBiosensors2025
A Unified YOLOv8 Approach for Point-of-Care Diagnostics of Salivary
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Salivary α-amylase (sAA) is a widely recognized biomarker for stress and autonomic nervous system activity. However, conventional enzymatic assays used to quantify sAA are limited by time-consuming, lab-based protocols. In this study, we present a portable, AI-driven point-of-care system for automated sAA classification via colorimetric image analysis. The system integrates SCHEDA, a custom-designed imaging device providing and ensuring standardized illumination, with a deep learning pipeline optimized for mobile deployment. Two classification strategies were compared: (1) a modular YOLOv4-CNN architecture and (2) a unified YOLOv8 segmentation-classification model. The models were trained on a dataset of 1024 images representing an eight-class classification problem corresponding to distinct sAA concentrations. The results show that red-channel input significantly enhances YOLOv4-CNN performance, achieving 93.5% accuracy compared to 88% with full RGB images. The YOLOv8 model further outperformed both approaches, reaching 96.5% accuracy while simplifying the pipeline and enabling real-time, on-device inference. The system was deployed and validated on a smartphone, demonstrating consistent results in live tests. This work highlights a robust, low-cost platform capable of delivering fast, reliable, and scalable salivary diagnostics for mobile health applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.